HIV-1 drug resistance and resistance testing.

@article{Clutter2016HIV1DR,
  title={HIV-1 drug resistance and resistance testing.},
  author={Dana S. Clutter and Michael R. Jordan and Silvia Bertagnolio and Robert W. Shafer},
  journal={Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases},
  year={2016},
  volume={46},
  pages={292-307}
}
The global scale-up of antiretroviral (ARV) therapy (ART) has led to dramatic reductions in HIV-1 mortality and incidence. However, HIV drug resistance (HIVDR) poses a potential threat to the long-term success of ART and is emerging as a threat to the elimination of AIDS as a public health problem by 2030. In this review we describe the genetic mechanisms, epidemiology, and management of HIVDR at both individual and population levels across diverse economic and geographic settings. To describe… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 5 times. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 17 extracted citations

HIV-1 Antiretroviral Resistance in Cuba , 2009 – 2014

Yoan Alemán-Campos, Lilia M Ortega-Gonzalez, +4 authors Ana L. Añé-Kourí
2018
View 1 Excerpt

References

Publications referenced by this paper.
Showing 1-10 of 192 references

Surveillance of HIV Drug Resistance in Resource Limited Countries Before and After Initiation of First - line Antiretroviral Traetment , 2006 - 1010

M. R. Jordan, J. Barcarolo, +7 authors H. R. A. S. Group
2016
View 20 Excerpts
Highly Influenced

HIV-1 Drug

S. Y. Rhee, M. R. Jordan, +29 authors R. W. Shafer
2015
View 20 Excerpts
Highly Influenced

Temporal changes in the epidemiology of transmission of drug-resistant HIV-1 across the world

D. Frentz, C. A. Boucher, D. A. van de Vijver
AIDS reviews • 2012
View 5 Excerpts
Highly Influenced

HIV drug resistance testing by high-multiplex "wide" sequencing on the MiSeq instrument.

Antimicrobial agents and chemotherapy • 2015
View 20 Excerpts
Highly Influenced

Lopinavir/Ritonavir Monotherapy as Second-line Antiretroviral Treatment in Resource-Limited Settings: Week 104 Analysis of AIDS Clinical Trials Group (ACTG) A5230.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America • 2015
View 18 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…